Showing 2,541 - 2,560 results of 12,750 for search '"therapeutics"', query time: 0.19s Refine Results
  1. 2541

    In vivo efficacy and safety of systemically administered serinol nucleic acid-modified antisense oligonucleotides in mouse kidney by Toshiki Tsuboi, Keita Hattori, Takuji Ishimoto, Kentaro Imai, Tomohito Doke, Junichiro Hagita, Jumpei Ariyoshi, Kazuhiro Furuhashi, Noritoshi Kato, Yasuhiko Ito, Yukiko Kamiya, Hiroyuki Asanuma, Shoichi Maruyama

    Published 2025-03-01
    “…Nucleic acid medicine encompassing antisense oligonucleotides (ASOs) has garnered interest as a potential avenue for next-generation therapeutics. However, their therapeutic application has been constrained by challenges such as instability, off-target effects, delivery issues, and immunogenic responses. …”
    Get full text
    Article
  2. 2542

    Comparative Efficacy of NAFLD Therapies and Biomarker Associations: A Meta-Analysis Based on Liver Fat Content by Haoxiang Zhu, Ling Xu, Yinhua Lv, Juan Yang, Jihan Huang, Qingshan Zheng, Guang Ji, Lujin Li

    Published 2025-01-01
    “…Background and Aims: This study aims to conduct a comprehensive quantitative analysis of various nonalcoholic fatty liver disease (NAFLD) therapeutics, utilizing magnetic resonance (MR)-detected liver fat content (LFC) as the efficacy endpoint, and to identify biomarkers correlated with changes in LFC based on published literature. …”
    Get full text
    Article
  3. 2543
  4. 2544
  5. 2545

    Development and Validation of the Digital Sensitivity Scale for Adults: Cross-Sectional Observational Study by Hae In Park, Minjeong Jeon, Ji Seon Ahn, Kyungmi Chung, Jin Young Park

    Published 2025-01-01
    “…This scale can play a pivotal role in enhancing compliance with digital therapeutics by preemptively assessing individuals’ technological literacy and competency.…”
    Get full text
    Article
  6. 2546
  7. 2547
  8. 2548

    Molecular Crosstalking among Noncoding RNAs: A New Network Layer of Genome Regulation in Cancer by Marco Ragusa, Cristina Barbagallo, Duilia Brex, Angela Caponnetto, Matilde Cirnigliaro, Rosalia Battaglia, Davide Barbagallo, Cinzia Di Pietro, Michele Purrello

    Published 2017-01-01
    “…Moreover, the pivotal role of ncRNAs as keystones of network structural integrity makes them very attractive and promising targets for innovative RNA-based therapeutics. In this review we will discuss: (1) the current knowledge on complex crosstalk among ncRNAs, with a special focus on cancer; and (2) the main issues and criticisms concerning ncRNAs targeting in therapeutics.…”
    Get full text
    Article
  9. 2549

    A comparison of Bartonella henselae infection in immunocompetent and immunocompromised mice. by Rebekah L Bullard, Mercedes Cheslock, Shiva Kumar Goud Gadila, Ricardo G Maggi, Edward B Breitschwerdt, Ahmad A Saied, Monica E Embers

    Published 2024-01-01
    “…These data indicate that SCID/Beige mice can provide a model to study Bartonella infection, therapeutics, and vector dynamics in the future.…”
    Get full text
    Article
  10. 2550
  11. 2551

    Milk-derived extracellular vesicles and gut health by Barathan Muttiah, Jia Xian Law

    Published 2025-01-01
    “…This review discusses the current understanding of milk-EVs’ effects on gut health, highlighting their potential therapeutic applications and future research directions. …”
    Get full text
    Article
  12. 2552
  13. 2553
  14. 2554

    PPARγ and Its Role in Cardiovascular Diseases by Mini Chandra, Sumitra Miriyala, Manikandan Panchatcharam

    Published 2017-01-01
    “…Finally, we also review the new PPARγ agonists under development as potential therapeutics with reduced or no adverse effects.…”
    Get full text
    Article
  15. 2555

    Update on glasdegib in acute myeloid leukemia – broadening horizons of Hedgehog pathway inhibitors by Fersing Cyril, Mathias Fanny

    Published 2022-03-01
    “…Numerous new emerging therapies, including oral targeted chemotherapies, have recently entered the therapeutic arsenal against acute myeloid leukemia (AML). …”
    Get full text
    Article
  16. 2556

    Technologies for Proteome-Wide Discovery of Extracellular Host-Pathogen Interactions by Nadia Martinez-Martin

    Published 2017-01-01
    “…Further development and application of technologies for genome-wide identification of extracellular protein interactions will be important in deciphering functional host-pathogen interaction networks, laying the foundation for development of novel therapeutics.…”
    Get full text
    Article
  17. 2557

    Unique Presentation and Management Approach of Pleural Solitary Fibrous Tumor by Tarek Aridi, Ayman Tawil, Mohamad Hashem, Joe Khoury, Roy A. Raad, Pierre Youssef

    Published 2019-01-01
    “…We report a case of a young female with a large, sessile, hypervascularized SFT of the pleura presenting with cardiopulmonary shock to a rural hospital with limited therapeutic interventions. We propose, in this case report, a unique multidisciplinary approach for the management of such a critical patient and the safe resection of the tumor.…”
    Get full text
    Article
  18. 2558

    Lessons from Cancer Immunoediting in Cutaneous Melanoma by Mariana Aris, María Marcela Barrio, José Mordoh

    Published 2012-01-01
    “…And finally, we will propose a rational discussion of the progress made and the future challenges in the therapeutics of Cutaneous Melanoma, taking into consideration that tumor evolution is the resulting from a continuous feedback between tumor cells and their environment, and that different combinatorial therapeutic approaches can be implemented according to the tumor stage.…”
    Get full text
    Article
  19. 2559

    AMPK-Dependent Metabolic Regulation by PPAR Agonists by Woo Hyung Lee, Sang Geon Kim

    Published 2010-01-01
    “…This intriguing action of PPAR agonists may account in part for the mechanistic basis of the therapeutics in the treatment of metabolic disease. In this paper, the effects of PPAR agonists on metabolic functions were summarized with particular reference to their AMPK activity regulation.…”
    Get full text
    Article
  20. 2560

    Recent Advances in ADAM17 Research: A Promising Target for Cancer and Inflammation by Marcia L. Moss, Dmitry Minond

    Published 2017-01-01
    “…The field of ADAM metalloproteinases is at a crossroad with many of the new potential therapeutic agents for ADAM17 advancing into the clinic. …”
    Get full text
    Article